Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Terri Williams

Emergency Medicine Saginaw, MI Medical Doctor

NPI 1720114507 CMS profile 168827

1500 Weiss St, Saginaw, MI 48602

Open in the dashboard

General payments

$2,879

168 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Terri Williams of Saginaw, MI is reported in the CMS Open Payments database as having received $2,879 across 168 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Emergency Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $378 23
2021 General $511 32
2020 General $583 38
2019 General $1,407 75

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Terri Williams
  • Emergency Medicine median
  • Middle half of Emergency Medicine
  • National median

In program year 2025, general payments to Terri Williams were reported at $0. Among 10,690 Emergency Medicine profiles paid that year, the median was $57 and the middle half received between $24 and $150.

Show as a table
Year Terri Williams Emergency Medicine median Middle half National median
2019 $1,407 $51 $18–$128 $163
2020 $583 $29 $16–$99 $114
2021 $511 $40 $18–$124 $132
2022 $378 $49 $20–$134 $149
2023 $0 $51 $22–$142 $160
2024 $0 $52 $22–$150 $164
2025 $0 $57 $24–$150 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Novo Nordisk Inc $574 36 payments
  2. AstraZeneca Pharmaceuticals LP $455 27 payments
  3. Janssen Pharmaceuticals, Inc $418 20 payments
  4. Amgen Inc. $308 13 payments
  5. Lilly USA, LLC $306 29 payments
  6. Bayer HealthCare Pharmaceuticals Inc. $154 3 payments
  7. AbbVie, Inc. $106 6 payments
  8. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $101 1 payment
  9. Takeda Pharmaceuticals U.S.A., Inc. $91 7 payments
  10. Pfizer Inc. $54 4 payments
  11. Other $312 22 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Food and Beverage $2,870 167 payments
  2. Education $8 1 payment
Products named General payments · program years 2019–2022
  1. Ozempic $436 27 payments
  2. XARELTO $418 20 payments
  3. FARXIGA $317 17 payments
  4. RYBELSUS $224 14 payments
  5. TRULICITY $221 22 payments
  6. SYMBICORT $210 7 payments
  7. Repatha $200 6 payments
  8. JARDIANCE $200 20 payments
  9. Adempas $125 1 payment
  10. Prolia $123 8 payments
  11. Other $1,545 105 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

168 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record